A Texas A&M University team of scientists and engineers is leading the development of a device that can be used to rapidly identify antibodies produced by human B cells that can neutralize infection by SARS-CoV-2, the causative agent of COVID-19.
Dr. Le Xie and his team are collaborating on a project to release a first-of-its-kind cross-domain, open access data hub to track the impact of the COVID-19 epidemic on electricity markets in the U.S.
Although surgeons control their telerobotic hands during operative procedures, accurately estimating how far these hands are from underlying tissue remains a challenge. Texas A&M researchers have found that delivering electrical pulses to fingertips is an effective, yet simple way to provide proximity information.
